REQUEST A DEMO
Total
USD $0.00
Search more companies

Instituto Cardiometabolico Cardiomet Plus S A S (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Instituto Cardiometabolico Cardiomet Plus S A S Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Instituto Cardiometabolico Cardiomet Plus S A S is an enterprise based in Colombia. Its main office is in Bogota D.C.. It operates in the Ambulatory Health Care Services industry. It was established on January 08, 2010. 6 (2023) employees currently work for Instituto Cardiometabolico Cardiomet Plus S A S. In 2023, the company reported a net sales revenue increase of 14.33%. Its total assets grew by 35.56% over the same period. In 2023, Instituto Cardiometabolico Cardiomet Plus S A S’s net profit margin increased by 10.6%.

Headquarters
Aut Norte Km 7
Bogota D.C.; Bogota D.C;

Contact Details: Purchase the Instituto Cardiometabolico Cardiomet Plus S A S report to view the information.

Basic Information
Total Employees:
Purchase the Instituto Cardiometabolico Cardiomet Plus S A S report to view the information.
Outstanding Shares:
Purchase the Instituto Cardiometabolico Cardiomet Plus S A S report to view the information.
Incorporation Date:
January 08, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Instituto Cardiometabolico Cardiomet Plus S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
14.33%
Total operating revenue
14.33%
Operating profit (EBIT)
12.25%
Net Profit (Loss) for the Period
59.07%
Total assets
35.56%
Total equity
44.4%
Operating Profit Margin (ROS)
-0.81%
Net Profit Margin
10.6%
Return on Equity (ROE)
2.84%
Quick Ratio
3.81%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?